0000919574-26-002327.txt : 20260422 0000919574-26-002327.hdr.sgml : 20260422 20260422110633 ACCESSION NUMBER: 0000919574-26-002327 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260422 DATE AS OF CHANGE: 20260422 EFFECTIVENESS DATE: 20260422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zakara Biotechnology Fund LP CENTRAL INDEX KEY: 0002058789 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-543714 FILM NUMBER: 26881939 BUSINESS ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 5TH FLOOR, SUITE 519 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-480-8420 MAIL ADDRESS: STREET 1: 300 PARK AVENUE STREET 2: 5TH FLOOR, SUITE 519 CITY: NEW YORK STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0002058789 Zakara Biotechnology Fund LP 300 PARK AVENUE 2ND FLOOR, SUITE 201 NEW YORK NY NEW YORK 10022 646 419 8761 DELAWARE None None Limited Partnership true 2025 - Zakara Capital LLC 300 PARK AVENUE 2nd Floor, Suite 201 New York NY NEW YORK 10022 Executive Officer Promoter Investment Manager - Zakara Biotechnology Fund GP LLC 300 PARK AVENUE 2nd Floor, Suite 201 New York NY NEW YORK 10022 Executive Officer Promoter General Partner Janet Okogbaa 300 PARK AVENUE 2nd Floor, Suite 201 New York NY NEW YORK 10022 Executive Officer Promoter Managing Member of the General Partner Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000919574-25-002456 2025-04-01 true true true false 0 Indefinite 15000 Indefinite false 1 0 true 0 true 0 true false Zakara Biotechnology Fund LP /s/ Janet Okogbaa Janet Okogbaa Managing Member of the General Partner 2026-04-22